WENG Cheng

Committed Research fellow with 3+ years of experience using cutting edge technology to generate and share important information with academic community. Networked with elite research teams from NUS and NYU institutions to develop and improve research protocols for field. Conducted complicated research with integrity and great attention to detail.

• Date of Birth: 12/08/92
• Nationality: China

0000-0001-7533-3457

• C. Weng, L. Shen, W. H. Ang* Harnessing Endogenous Formate for Antibacterial Prodrug Activation by in cellulo Ruthenium-mediated Transfer Hydrogenation Reaction. Angew. Chem. Int. Ed.2020, 59, 9314–9318.
• C. Weng*, L. Shen, J. W. Teo, Z. C. Lim, B. S. Loh, W. H. Ang* Targeted Antibacterial Strategy Based on Reactive Oxygen Species Generated from Dioxygen Reduction Using an Organoruthenium Complex. JACS Au 2021, 1, 1348–1354.
• C. Weng, H. Yang, B. S. Loh, M. W. Wong*, W. H. Ang* Targeting Pathogenic Formate-Dependent Bacteria with Bioinspired Metallo-Nitroreductase Complex. J. Am. Chem. Soc. 2023, 145, 6453–6461. (JACS Spotlights)
• C. Weng, K. Y. L. Tan, G. K. Wayne, W. H. Ang* Harnessing Transition Metal Scaffolds for Targeted Antibacterial Therapy. Angew. Chem. Int. Ed.2023, e202310040.
• M. Orsi,‡ B. S. Loh,‡ C. Weng,‡ W. H. Ang,* A. Frei* Using Machine Learning to Predict the Antibacterial Activity of Ruthenium Complexes, Angew. Chem. Int. Ed. 2023, e202317901
• B. S. Loh, S. W. Yong, C. Weng*, W. H. Ang* Photoclickable Latch with In-Built Palladium-Mediated Release Mechanism. (J. Am. Chem. Soc.Under minor revision)
• Z.-Q. Rong, Z. Yu, C. Weng, L.-C. Yang, S. Lu, Y. Lan, Y. Zhao Dynamic Kinetic Asymmetric Amination of Alcohols Assisted by Microwave: Stereo-convergent Access to Tetralin- and Indane-Derived Chiral Amines. ACS Catal. 2020, 10.
• H. Shen, C. Zhang, K. S. Wun, J. Liu, S. P. Nadarajan, C. Weng, H. Ling, J. K Tay, D. Y. Wang, S. Q. Yao, I. Y. Hwang,* Y. S. Lee, M. W. Chang* Prodrug-Conjugated Tumor-Seeking Commensals for Targeted Cancer Therapy. (Nat. Commun. Under minor revision)
• C. Weng, R. W. Toh, J. Wu*, W. H. Ang* Antibacterial Photodynamic Therapy Capitalizing on Efficient Type I Organic Photosensitizers with High ROS-Generation Capability to Combat Drug Resistance. (Patent serial no. 10202260303V)
• C. Weng, J. Xu, J. Wu*, W. H. Ang* Metal-Free Organo-Photocatalysts for Non-Sacrificial Artificial Hydrogen Peroxide Production. (J. Am. Chem. Soc. submitted)
• C. Weng*, C. S. Lim, W. H. Ang* Targeted Anticancer Chemotherapy Leveraging on Differential Mitochondrial Copper Homeostasis. (Manuscript in Preparation)
• C. Weng, R. W. Toh, J. Wu*, W. H. Ang* Antibacterial Photodynamic Therapy Capitalizing on Novel Hybrid Organic Photosensitizers to Eradicate Multidrug-Resistant Pathogens. (Manuscript in Preparation)

• Best Poster Award in Twentieth International Conference on Biological Inorganic Chemistry (ICBIC20)
• Travel Award in 10th Asian Biological Inorganic Chemistry Conference (AsBIC10)
• Outstanding Research Achievement Award-National University of Singapore
• Supervision Award for the Best Master Dissertation -National University of Singapore
• Academic Excellence (First Class)-Soochow University
• Top Award for Study Abroad Exchange Program-Soochow University